Moreover, in addition to mitochondria-generated and tumor-derived ROS, MDSCs produce a great deal of ROS in the TME through NADPH oxidase 2 (NOX2), which reduces CD3ζ expression in T lymphocytes, thereby limiting T lymphocyte activation and corresponding IFN-γ expression (59). This evidence concerns the gene CYBB and neoplasm.